Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04256889 · ClinicalTrials.gov registry record · NA
Use Of Nfant(R) Technology Feeding System For Infants Less Than 30 Weeks GA
A NA study, sponsored by Woman's.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04256889: Completed NA study, sponsored by Woman's.
NCT04256889 is a NA study that has completed, run by Woman's. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04256889, a NA study, has completed, sponsored by Woman's.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of the study is to utilize the objective data provided by the nfant® suite of products, along with current NICU visual assessment and cue-based feeding practices, in order to determine if feeding performance outcomes and clinical decision making for individualized feeding plans for premature infants born less than 30 weeks PMA are impacted.
Primary Outcome
Starts when an infant can take 5 ml of breast milk or formula orally with autonomic stability
Interventions
- DEVICE nfant(R) feeding system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2020-01-15 |
| Est. Completion | 2024-03-13 |
| Phase | NA |
What the finished NCT04256889 record still lists
NCT04256889 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which nfant(R) feeding system is the first listed.
NCT04256889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04256889 about?
NCT04256889 is a clinical study titled "Use Of Nfant(R) Technology Feeding System For Infants Less Than 30 Weeks GA". The purpose of the study is to utilize the objective data provided by the nfant® suite of products, along with current NICU visual assessment and cue-based feeding practices, in order to determine if feeding performance outcomes and clinical decision making for individualized feeding plans for prema...
What is the current status of trial NCT04256889?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2020-01-15. Estimated completion is 2024-03-13.
What interventions are being tested in trial NCT04256889?
The interventions under investigation include: nfant(R) feeding system (DEVICE).
Who is sponsoring clinical trial NCT04256889?
This trial is sponsored by Woman's, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04256889's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI